AGN News 166.61 04/24/2014 20:53:33 Allergan Inc (AGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Inc (AGN) 166.61 $AGN

Update on Glaxo/Theravance's COPD Drugs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 5:33PM CDT
Glaxo (GSK) and partner Theravance (THRX) announced the initiation of a phase III study on Relvar Ellipta.

Inside Valeant Pharmaceuticals' Bid for Allergan
Brendan Mathews, The Motley Fool - Motley Fool - Thu Apr 24, 5:30PM CDT
Earlier this week, Valeant Pharmaceutical made a public offer to buy rival Allergan . Let's review the major questions this huge potential deal raises, to see whether it's a smart move – and whether or not it'll actually happen. What is...

Valeant Eyes Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 4:40PM CDT
Shares of Allergan (AGN) gained 15.2% after Valeant Pharmaceuticals International, Inc. (VRX) and Pershing Square Capital Management, L.P made a formal proposal to acquire the former.

Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available
CNW Group - Thu Apr 24, 2:16PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) and Pershing Square Capital Management L.P. ("Pershing Square" today announced that they have released the webcast replay and accompanying presentations from the April 22, 2014 investor meeting featuring Valeant Chairman and Chief Executive Officer, J. Michael Pearson and Pershing Square Chief Executive Officer, William A. Ackman, outlining Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN). The webcast and presentations can be accessed by visiting www.vpsevent.com/webcast.

Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 12:50PM CDT
Eli Lilly's (LLY) first quarter revenues were hurt by the genericization of two major products - Cymbalta and Evista.

Zimmer Bolts on Biomet for $13.4B
at The Street - Thu Apr 24, 10:47AM CDT
Sponsors Blackstone, TPG, KKR and Goldman forgo planned IPO in sale of orthopedic device maker.

Botox at the Center of Recent Healthcare M&A Flurry
at The Street - Thu Apr 24, 10:07AM CDT
How wrinkle reduction is at the crux of the recent M&A frenzy....

Jim Cramer's 'Mad Money' Recap: The Market's New Reality
at The Street - Wed Apr 23, 7:20PM CDT
Investors are focusing on the positive instead of the negative, Cramer says.

Encouraging Results from Pfizer's Xeljanz - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 5:20PM CDT
Pfizer Inc. (PFE) announced encouraging top-line results from two pivotal phase III studies from the OPT Program on Xeljanz.

Fitch Places Allergan's Ratings on Negative Watch
Business Wire - Wed Apr 23, 2:32PM CDT
Fitch Ratings has placed the ratings for Allergan Inc. (Allergan), including the 'A+' Issuer Default Rating (IDR), on Rating Watch Negative. The rating action stems from Valeant Pharmaceuticals International Inc.'s (Valeant) unsolicited offer to acquire Allergan for approximately $45.6 billion. The rating action applies to $2.1 billion of outstanding Allergan debt. A complete list of ratings is provided at the end of this release.

Can Allergan Find an Alternative To Valeant?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 23, 1:30PM CDT
No one will accuse Valeant CEO Mike Pearson of lacking boldness. He has laid out a strategy for turning Valeant into one of the largest pharmaceutical/med-tech companies in the world and has proven more than willing to turn to bold...

Stock Market News for April 23, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 9:06AM CDT
Benchmarks ended higher on Tuesday boosted by better-than-expected corporate results

Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver
PR Newswire - Wed Apr 23, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AGN, SUNE, VRX, SHPG, and PAYX.

Stock Price Movements, Collaborations, Earnings Releases, Upcoming Earnings and Conference Call Schedules, and Legal Updates - Analyst Notes on Allergan, Aetna, Abbott, Amgen and Medtronic
PR Newswire - Wed Apr 23, 8:30AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Aetna Inc. (NYSE: AET), Abbott Laboratories (NYSE: ABT), Amgen Inc. (NASDAQ: AMGN) and Medtronic Inc. (NYSE: MDT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1477-100free.

Allergan, Inc.: Another Billion-Dollar Buyout Target
Max Macaluso and Michael Douglass, The Motley Fool - Motley Fool - Wed Apr 23, 8:15AM CDT
Earlier this week, investors following the pharmaceutical industry may have been surprised to hear that Pfizer was interested in acquiring AstraZeneca . However, the billion-dollar buyout news didn't stop there. Yesterday, shares of Allergan ,...

Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Beth Nichols, The Motley Fool - Motley Fool - Wed Apr 23, 7:50AM CDT
Valeant Pharmaceuticals  announced yesterday that it plans to acquire Allergan with the help of investor Bill Ackerman. Should the plan succeed, the acquisition would create a dermatology and ophthalmology giant and bring a number of the leading...

Allergan Inc. (AGN) in Focus: Stock Rallies 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:44AM CDT
Allergan Inc. was a big mover last session, as the company saw its shares surge over 15.0% on the day.

How Will Allergan (AGN) Stock Be Affected By Poison Pill Stance Against Valeant (VRX), Ackman?
at The Street - Wed Apr 23, 7:22AM CDT
Shares of Allergan (AGN) are slightly higher in pre-market trade after the health care company adopted a poison pill defense against the unsolicited $46 billion bid takeover from Valeant Pharmaceuticals (VRX) and activist investor Bill Ackman.

Downgrade Alert for Allergan (AGN)
Comtex SmarTrend(R) - Wed Apr 23, 6:57AM CDT
Allergan (AMEX:AGN) was downgraded from Buy to Hold at Argus Research today. The stock closed yesterday at $163.65 on volume of 32.4 million shares, above average daily volume of 3.4 million. In the past 52 weeks, shares of Allergan have traded between a low of $81.33 and a high of $165.45 and closed yesterday at $163.65, which is 101% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 1.1%.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 157

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
HashKey and Base Aim to Bridge Asia With Liquidity

Updated Category News Views 79

A blockchain partnership can sound like confetti until the plumbing matters. This one at least points at a real commercial choke point: Asian-originated tokenized assets need deeper pools of global onchain capital, while global networks need credible asset supply and institutional access. HashKey Group's HSK Chain and Coinbase-built Base say they intend to tackle both...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 91

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 227

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 127

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 25

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
PSEG Declares $0.67 Fourth-Quarter 2026 Cash Dividend

Updated Category News Views 159

A 67-cent utility dividend rarely sets the tape on fire, and that is precisely the point. Public Service Enterprise Group declared a regular fourth-quarter 2026 common-stock dividend of $0.67 per share, payable on or before December 31 to shareholders of record on December 10. For owners of NYSE:PEG, this is the sort of announcement that belongs in the “steady as she...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 42

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 182

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading

Top 5 Most Recently Viewed Articles

TRUBAR Inc. Takes Bold Steps with Personal Care Product Sale

Updated Category News Views 169

TRUBAR Inc. Streamlines Focus with Recent Asset Sale TRUBAR Inc. is making significant moves to streamline its operations and focus on its core identity as a leading provider of plant-based protein products. The company has announced that it has successfully sold the assets related to its personal care product line through its subsidiary, NO BS Life, LLC. This strategic...

Continue Reading
Advancements in Squamous Cell Carcinoma Treatments Unveiled

Updated Category News Views 362

Examining Treatments for Squamous Cell Carcinoma The landscape of squamous cell carcinoma (SCC) treatments is rapidly evolving. This shift is largely driven by the increasing number of diagnosed cases. As public awareness rises and exposure to risk factors like ultraviolet (UV) radiation continues, healthcare professionals and researchers are persistently seeking...

Continue Reading
Millennium Physician Group and IMA Medical Group Unite for Better Care

Updated Category News Views 327

Millennium Physician Group and IMA Medical Group Unite for Better Patient Care In an exciting development for healthcare in Central Florida, Millennium Physician Group has announced its collaboration with IMA Medical Group. This partnership represents a major step forward in expanding value-based, patient-centered care to the local communities. About the New Partnership...

Continue Reading
Innovative Partnership to Revolutionize Osteoporosis Detection

Updated Category News Views 96

Strategic Alliance to Enhance Osteoporosis Awareness Naitive Technologies Ltd., a leader in population health innovation focused on musculoskeletal care, has embarked on an important partnership with Parvizi Surgical Innovation (PSI). This collaboration aims to significantly improve the detection and clinical management of osteoporosis, particularly through the use of...

Continue Reading
Storm and Fire Survivors Unite at U.S. Capitol for Aid

Updated Category News Views 451

Storm and Fire Survivors Unite at U.S. Capitol for Aid Recently, over fifty storm and fire survivors convened at the U.S. Capitol to advocate for robust disaster relief and a more effective recovery system for affected families and communities, in an event organized by Organizing Resilience. These brave individuals came together to share their compelling stories,...

Continue Reading